Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

UBS Initiates Coverage On Addus HomeCare with Buy Rating, Announces Price Target of $145

Author: Benzinga Newsdesk | September 02, 2025 08:11am
UBS analyst A.J. Rice initiates coverage on Addus HomeCare (NASDAQ:ADUS) with a Buy rating and announces Price Target of $145.

Posted In: ADUS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist